Novel discoveries targeting gemcitabine‐based chemoresistance and new therapies in pancreatic cancer: How far are we from the destination?

Pancreatic cancer (PC) remains one of the deadliest malignancies worldwide. Chemoresistance is a significant clinical problem in pancreatic ductal adenocarcinoma (PDAC) and numerous potential mechanisms have been demonstrated but much remains to be understood. To overcome the existing limitations in...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Wenhao, Yang, Gang, Qiu, Jiangdong, Luan, Jingyang, Zhang, Ying, You, Lei, Feng, Mengyu, Zhao, Fangyu, Liu, Yueze, Cao, Zhe, Zheng, Lianfang, Zhang, Taiping, Zhao, Yupei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Cancer Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797580/
https://www.ncbi.nlm.nih.gov/pubmed/31475468
http://dx.doi.org/10.1002/cam4.2384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797580/
https://www.ncbi.nlm.nih.gov/pubmed/31475468
http://dx.doi.org/10.1002/cam4.2384

Ejemplares similares